Lunit Inc.
Research Lunit Inc. (328130.KQ) on Bullrun: market cap KRW 881.58B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker328130.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryHealth Information Services
- CurrencyKRW
- Market capKRW 881.58B
- Financial periodQ2 2026
- RevenueKRW 21.81B
- Net income-KRW 23.56B
- Free cash flow-KRW 14.87B
- Gross margin100.0%
Valuation Snapshot
latest market cap is KRW 881.58B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 881.58B | n/a | n/a | n/a |
Dividend history
About Lunit Inc.
Lunit Inc. provides AI-powered software and solutions for cancer diagnostics and therapeutics in South Korea. It offers AI solution for chest X-ray and mammography, as well as AI solution for digital breast tomosynthesis, and AI-powered biomarker for immune phenotyping and PD-L1 biomarker analyzer.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Lunit Inc.'s market cap?
Lunit Inc.'s market capitalization is KRW 881.58B.
What does Lunit Inc. do?
Lunit Inc. provides AI-powered software and solutions for cancer diagnostics and therapeutics in South Korea. It offers AI solution for chest X-ray and mammography, as well as AI solution for digital breast tomosynthesis, and AI-powered biomarker for immune phenotyping and PD-L1 biomarker analyzer.